SCHEMBL8901720

SCHEMBL8901720

CC1OC(C(=O)O)CC2=C1C(=O)C=CC2=O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DNMT3B Q9UBC3 1/20 0.32
HSP90AA1 P07900 1/20 0.32
PAX8 Q06710 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
CTH P32929 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900585 0.71
SCHEMBL8527887 0.70
SCHEMBL27354248 0.69 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL9522522 0.69
SCHEMBL8903142 0.68 IDO1 (0.33) SMN1; SMN2
SCHEMBL9523532 0.63
SCHEMBL8903248 0.63 AKT1 (0.30)
SCHEMBL8900793 0.63 AKT1 (0.34)
SCHEMBL8913970 0.63
SCHEMBL30446083 0.62 SMN1; SMN2 (0.38) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed
EP-0533744-A1 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1993-03-31 EP disclosed
CN-1058781-A New heterocyclic anthracycline hydrocarbon homologue IAF BIOCHEM INT (CA) 1992-02-19 CN disclosed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO disclosed